Drug Research
Neurocrine and Takeda Ink $2 Billion-Plus Neuroscience Development Deal
San Diego-based Neurocrine Biosciences is partnering with Japan’s Takeda Pharmaceutical to develop and commercialize molecules in Takeda’s early-to-mid-stage psychiatry pipeline. Takeda granted an exclusive license...
Drug Research
Saiba AG Selects AGC Biologics to Develop and Produce...
AGC Biologics, a global biopharmaceutical Contract Development Manufacturing Organization (CDMO), has announced it will be partnering with Saiba AG to manufacture a SARS-CoV-2 vaccine to...
Drug Research
Catalent Signs Agreement with AstraZeneca to Manufacture COVID-19 Vaccine...
Catalent, Inc. , the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health...
Drug Research
Fujifilm to invest 100 billion yen to expand its...
FUJIFILM Corporation will make a major capital investment of approximately 100 billion yen (928 million USD) in the Denmark site of FUJIFILM Diosynth Biotechnologies, a...
Drug Research
The University of Queensland, CEPI and CSL partner to...
CEPI, the Coalition for Epidemic Preparedness Innovations, CSL and The University of Queensland announced that they have entered into a new, significant partnering agreement to...
Drug Research
Airway Therapeutics and Celonic Group Collaborate to Produce AT-100...
Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and...
Drug Research
Merck and Ridgeback Bio Collaborate to Advance Development of...
Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics LP, a closely held biotechnology company, announced that the companies have entered...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.